RECENT FUNDING
  1. Recent Funding
  2. Founders
  3. Daniel Nadler
Daniel NadlerDN

Daniel Nadler

Founder, OpenEvidence · OOpenEvidence
About Daniel

Daniel Nadler is the founder of OpenEvidence, an AI platform designed to assist healthcare professionals by providing access to medical information. The platform helps doctors search medical literature and review cited information relevant to clinical questions. Nadler previously founded Kensho and co-founded EDO. He holds a Ph.D. from Harvard University.

PATH · 7 MILESTONES

Daniel Nadler | From Kensho to OpenEvidence, AI in Healthcare

2025 → 2026·0phases·now
20252026Feb 20, 2025: OpenEvidence raised $75M (Series A), led by Sequoia. $75M SERIES A · FEB '25 Jul 15, 2025: OpenEvidence raised $210M (Series B+), led by GV and Kleiner Perkins. $210M SERIES B+ · JUL '25 Oct 20, 2025: OpenEvidence raised $200M (Series B+), led by GV. $200M SERIES B+ · OCT '25 Jan 21, 2026: OpenEvidence raised $250M (Series B+), led by DST Global and Thrive Capital. $250M SERIES B+ · JAN '26 May 13, 2026: Discusses OpenEvidence's ad-supported model and future plans. | DISCUSSES BUSINESS MODEL | Sep 23, 2026: OpenEvidence expands free AI clinical tool to 100 countries in collaboration with Anthropic. | GLOBAL EXPANSION | Sep 24, 2026: OpenEvidence raised $250M (Series B+), led by Andreessen Horowitz and hospital systems. $250M SERIES B+ · SEP '26

Every tag links its source.

Network

Background

1
  • Role CEO of OpenEvidence
    N
Timeline, line by line 7

In their words

1
  • “Access to medical knowledge shouldn’t depend on geography.”Regarding the expansion of OpenEvidence to low- and middle-income countries. · Sep 23, 2026
    T

Interviews and coverage

7
How this is researched

Researched from public pages: press, interviews, the company's site and the founder's own posts. Each source logo links the page that states the row; anything we couldn't source is left out. The archetype is our reading of that record, from a fixed set so founders can be compared. Updated Oct 12, 2026.

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy